⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

VVOS News

Vivos Therapeutics, Inc. Common Stock

Vivos Therapeutics Releases Additional Clinical Data Showing Marked Improvement in Pediatric ADHD from Use of Vivos DNA Device